As of Jul 29
| +0.04 / +1.29%|
The 8 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 9.75, with a high estimate of 13.75 and a low estimate of 8.00. The median estimate represents a +211.50% increase from the last price of 3.13.
The current consensus among 8 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.